- IBDEI1H6 ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,23862,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23862,1,3,0)
- ;;=3^Heart Failure,End Stage
- ;;^UTILITY(U,$J,358.3,23862,1,4,0)
- ;;=4^I50.84
- ;;^UTILITY(U,$J,358.3,23862,2)
- ;;=^5151391
- ;;^UTILITY(U,$J,358.3,23863,0)
- ;;=I50.89^^82^1033^11
- ;;^UTILITY(U,$J,358.3,23863,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23863,1,3,0)
- ;;=3^Heart Failure,Other
- ;;^UTILITY(U,$J,358.3,23863,1,4,0)
- ;;=4^I50.89
- ;;^UTILITY(U,$J,358.3,23863,2)
- ;;=^5151392
- ;;^UTILITY(U,$J,358.3,23864,0)
- ;;=E03.9^^82^1034^21
- ;;^UTILITY(U,$J,358.3,23864,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23864,1,3,0)
- ;;=3^Hypothyroidism,Unspec
- ;;^UTILITY(U,$J,358.3,23864,1,4,0)
- ;;=4^E03.9
- ;;^UTILITY(U,$J,358.3,23864,2)
- ;;=^5002476
- ;;^UTILITY(U,$J,358.3,23865,0)
- ;;=E11.9^^82^1034^13
- ;;^UTILITY(U,$J,358.3,23865,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23865,1,3,0)
- ;;=3^DM Type 2 w/o Complications
- ;;^UTILITY(U,$J,358.3,23865,1,4,0)
- ;;=4^E11.9
- ;;^UTILITY(U,$J,358.3,23865,2)
- ;;=^5002666
- ;;^UTILITY(U,$J,358.3,23866,0)
- ;;=E10.9^^82^1034^7
- ;;^UTILITY(U,$J,358.3,23866,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23866,1,3,0)
- ;;=3^DM Type 1 w/o Complications
- ;;^UTILITY(U,$J,358.3,23866,1,4,0)
- ;;=4^E10.9
- ;;^UTILITY(U,$J,358.3,23866,2)
- ;;=^5002626
- ;;^UTILITY(U,$J,358.3,23867,0)
- ;;=E11.65^^82^1034^9
- ;;^UTILITY(U,$J,358.3,23867,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23867,1,3,0)
- ;;=3^DM Type 2 w/ Hyperglycemia
- ;;^UTILITY(U,$J,358.3,23867,1,4,0)
- ;;=4^E11.65
- ;;^UTILITY(U,$J,358.3,23867,2)
- ;;=^5002663
- ;;^UTILITY(U,$J,358.3,23868,0)
- ;;=E10.65^^82^1034^5
- ;;^UTILITY(U,$J,358.3,23868,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23868,1,3,0)
- ;;=3^DM Type 1 w/ Hyperglycemia
- ;;^UTILITY(U,$J,358.3,23868,1,4,0)
- ;;=4^E10.65
- ;;^UTILITY(U,$J,358.3,23868,2)
- ;;=^5002623
- ;;^UTILITY(U,$J,358.3,23869,0)
- ;;=E11.8^^82^1034^8
- ;;^UTILITY(U,$J,358.3,23869,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23869,1,3,0)
- ;;=3^DM Type 2 w/ Complications,Unspec
- ;;^UTILITY(U,$J,358.3,23869,1,4,0)
- ;;=4^E11.8
- ;;^UTILITY(U,$J,358.3,23869,2)
- ;;=^5002665
- ;;^UTILITY(U,$J,358.3,23870,0)
- ;;=E10.8^^82^1034^4
- ;;^UTILITY(U,$J,358.3,23870,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23870,1,3,0)
- ;;=3^DM Type 1 w/ Complications,Unspec
- ;;^UTILITY(U,$J,358.3,23870,1,4,0)
- ;;=4^E10.8
- ;;^UTILITY(U,$J,358.3,23870,2)
- ;;=^5002625
- ;;^UTILITY(U,$J,358.3,23871,0)
- ;;=E53.8^^82^1034^31
- ;;^UTILITY(U,$J,358.3,23871,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23871,1,3,0)
- ;;=3^Vitamin B Group Deficiency
- ;;^UTILITY(U,$J,358.3,23871,1,4,0)
- ;;=4^E53.8
- ;;^UTILITY(U,$J,358.3,23871,2)
- ;;=^5002797
- ;;^UTILITY(U,$J,358.3,23872,0)
- ;;=E78.5^^82^1034^20
- ;;^UTILITY(U,$J,358.3,23872,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23872,1,3,0)
- ;;=3^Hyperlipidemia,Unspec
- ;;^UTILITY(U,$J,358.3,23872,1,4,0)
- ;;=4^E78.5
- ;;^UTILITY(U,$J,358.3,23872,2)
- ;;=^5002969
- ;;^UTILITY(U,$J,358.3,23873,0)
- ;;=E66.9^^82^1034^28
- ;;^UTILITY(U,$J,358.3,23873,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23873,1,3,0)
- ;;=3^Obesity,Unspec
- ;;^UTILITY(U,$J,358.3,23873,1,4,0)
- ;;=4^E66.9
- ;;^UTILITY(U,$J,358.3,23873,2)
- ;;=^5002832
- ;;^UTILITY(U,$J,358.3,23874,0)
- ;;=E66.01^^82^1034^26
- ;;^UTILITY(U,$J,358.3,23874,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,23874,1,3,0)
- ;;=3^Morbid Obesity d/t Excess Calories
- ;;^UTILITY(U,$J,358.3,23874,1,4,0)
- ;;=4^E66.01
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1H6 3763 printed Feb 18, 2025@23:34:59 Page 2
- IBDEI1H6 ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,23862,1,0)
- +2 ;;=^358.31IA^4^2
- +3 ;;^UTILITY(U,$J,358.3,23862,1,3,0)
- +4 ;;=3^Heart Failure,End Stage
- +5 ;;^UTILITY(U,$J,358.3,23862,1,4,0)
- +6 ;;=4^I50.84
- +7 ;;^UTILITY(U,$J,358.3,23862,2)
- +8 ;;=^5151391
- +9 ;;^UTILITY(U,$J,358.3,23863,0)
- +10 ;;=I50.89^^82^1033^11
- +11 ;;^UTILITY(U,$J,358.3,23863,1,0)
- +12 ;;=^358.31IA^4^2
- +13 ;;^UTILITY(U,$J,358.3,23863,1,3,0)
- +14 ;;=3^Heart Failure,Other
- +15 ;;^UTILITY(U,$J,358.3,23863,1,4,0)
- +16 ;;=4^I50.89
- +17 ;;^UTILITY(U,$J,358.3,23863,2)
- +18 ;;=^5151392
- +19 ;;^UTILITY(U,$J,358.3,23864,0)
- +20 ;;=E03.9^^82^1034^21
- +21 ;;^UTILITY(U,$J,358.3,23864,1,0)
- +22 ;;=^358.31IA^4^2
- +23 ;;^UTILITY(U,$J,358.3,23864,1,3,0)
- +24 ;;=3^Hypothyroidism,Unspec
- +25 ;;^UTILITY(U,$J,358.3,23864,1,4,0)
- +26 ;;=4^E03.9
- +27 ;;^UTILITY(U,$J,358.3,23864,2)
- +28 ;;=^5002476
- +29 ;;^UTILITY(U,$J,358.3,23865,0)
- +30 ;;=E11.9^^82^1034^13
- +31 ;;^UTILITY(U,$J,358.3,23865,1,0)
- +32 ;;=^358.31IA^4^2
- +33 ;;^UTILITY(U,$J,358.3,23865,1,3,0)
- +34 ;;=3^DM Type 2 w/o Complications
- +35 ;;^UTILITY(U,$J,358.3,23865,1,4,0)
- +36 ;;=4^E11.9
- +37 ;;^UTILITY(U,$J,358.3,23865,2)
- +38 ;;=^5002666
- +39 ;;^UTILITY(U,$J,358.3,23866,0)
- +40 ;;=E10.9^^82^1034^7
- +41 ;;^UTILITY(U,$J,358.3,23866,1,0)
- +42 ;;=^358.31IA^4^2
- +43 ;;^UTILITY(U,$J,358.3,23866,1,3,0)
- +44 ;;=3^DM Type 1 w/o Complications
- +45 ;;^UTILITY(U,$J,358.3,23866,1,4,0)
- +46 ;;=4^E10.9
- +47 ;;^UTILITY(U,$J,358.3,23866,2)
- +48 ;;=^5002626
- +49 ;;^UTILITY(U,$J,358.3,23867,0)
- +50 ;;=E11.65^^82^1034^9
- +51 ;;^UTILITY(U,$J,358.3,23867,1,0)
- +52 ;;=^358.31IA^4^2
- +53 ;;^UTILITY(U,$J,358.3,23867,1,3,0)
- +54 ;;=3^DM Type 2 w/ Hyperglycemia
- +55 ;;^UTILITY(U,$J,358.3,23867,1,4,0)
- +56 ;;=4^E11.65
- +57 ;;^UTILITY(U,$J,358.3,23867,2)
- +58 ;;=^5002663
- +59 ;;^UTILITY(U,$J,358.3,23868,0)
- +60 ;;=E10.65^^82^1034^5
- +61 ;;^UTILITY(U,$J,358.3,23868,1,0)
- +62 ;;=^358.31IA^4^2
- +63 ;;^UTILITY(U,$J,358.3,23868,1,3,0)
- +64 ;;=3^DM Type 1 w/ Hyperglycemia
- +65 ;;^UTILITY(U,$J,358.3,23868,1,4,0)
- +66 ;;=4^E10.65
- +67 ;;^UTILITY(U,$J,358.3,23868,2)
- +68 ;;=^5002623
- +69 ;;^UTILITY(U,$J,358.3,23869,0)
- +70 ;;=E11.8^^82^1034^8
- +71 ;;^UTILITY(U,$J,358.3,23869,1,0)
- +72 ;;=^358.31IA^4^2
- +73 ;;^UTILITY(U,$J,358.3,23869,1,3,0)
- +74 ;;=3^DM Type 2 w/ Complications,Unspec
- +75 ;;^UTILITY(U,$J,358.3,23869,1,4,0)
- +76 ;;=4^E11.8
- +77 ;;^UTILITY(U,$J,358.3,23869,2)
- +78 ;;=^5002665
- +79 ;;^UTILITY(U,$J,358.3,23870,0)
- +80 ;;=E10.8^^82^1034^4
- +81 ;;^UTILITY(U,$J,358.3,23870,1,0)
- +82 ;;=^358.31IA^4^2
- +83 ;;^UTILITY(U,$J,358.3,23870,1,3,0)
- +84 ;;=3^DM Type 1 w/ Complications,Unspec
- +85 ;;^UTILITY(U,$J,358.3,23870,1,4,0)
- +86 ;;=4^E10.8
- +87 ;;^UTILITY(U,$J,358.3,23870,2)
- +88 ;;=^5002625
- +89 ;;^UTILITY(U,$J,358.3,23871,0)
- +90 ;;=E53.8^^82^1034^31
- +91 ;;^UTILITY(U,$J,358.3,23871,1,0)
- +92 ;;=^358.31IA^4^2
- +93 ;;^UTILITY(U,$J,358.3,23871,1,3,0)
- +94 ;;=3^Vitamin B Group Deficiency
- +95 ;;^UTILITY(U,$J,358.3,23871,1,4,0)
- +96 ;;=4^E53.8
- +97 ;;^UTILITY(U,$J,358.3,23871,2)
- +98 ;;=^5002797
- +99 ;;^UTILITY(U,$J,358.3,23872,0)
- +100 ;;=E78.5^^82^1034^20
- +101 ;;^UTILITY(U,$J,358.3,23872,1,0)
- +102 ;;=^358.31IA^4^2
- +103 ;;^UTILITY(U,$J,358.3,23872,1,3,0)
- +104 ;;=3^Hyperlipidemia,Unspec
- +105 ;;^UTILITY(U,$J,358.3,23872,1,4,0)
- +106 ;;=4^E78.5
- +107 ;;^UTILITY(U,$J,358.3,23872,2)
- +108 ;;=^5002969
- +109 ;;^UTILITY(U,$J,358.3,23873,0)
- +110 ;;=E66.9^^82^1034^28
- +111 ;;^UTILITY(U,$J,358.3,23873,1,0)
- +112 ;;=^358.31IA^4^2
- +113 ;;^UTILITY(U,$J,358.3,23873,1,3,0)
- +114 ;;=3^Obesity,Unspec
- +115 ;;^UTILITY(U,$J,358.3,23873,1,4,0)
- +116 ;;=4^E66.9
- +117 ;;^UTILITY(U,$J,358.3,23873,2)
- +118 ;;=^5002832
- +119 ;;^UTILITY(U,$J,358.3,23874,0)
- +120 ;;=E66.01^^82^1034^26
- +121 ;;^UTILITY(U,$J,358.3,23874,1,0)
- +122 ;;=^358.31IA^4^2
- +123 ;;^UTILITY(U,$J,358.3,23874,1,3,0)
- +124 ;;=3^Morbid Obesity d/t Excess Calories
- +125 ;;^UTILITY(U,$J,358.3,23874,1,4,0)
- +126 ;;=4^E66.01